'Big deal': lives saved with antibiotic breakthrough for horrendous infection
A clinical trial co-led by the University of Newcastle has identified safer and more effective antibiotics for treating golden staph blood infections. The study suggests that cefazolin and penicillin are better alternatives to the previously standard flucloxacillin.
Why it matters
This medical breakthrough could prevent approximately 30 deaths annually in the Hunter region and improve treatment outcomes for a common, deadly bacterial infection globally.
+ 1 About 30 deaths a year will be prevented in the Hunter, after a clinical trial made a breakthrough in the treatment of golden staph blood infections.
The article reports on scientific findings and clinical trial results.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in